Company news
Connect Biopharma Holdings Limited news in 2026
Connect Biopharma Holdings Limited's news releases, calls and decks from 2026, newest first.
Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update
November 16, 2026
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation
September 30, 2026
Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation
September 15, 2026
Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
June 17, 2026
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
May 12, 2026
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis
April 22, 2026
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
March 30, 2026
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
March 29, 2026
Connect Biopharma Announces $20.2 Million Private Placement Financing
March 29, 2026
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
March 10, 2026
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
March 3, 2026
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 19, 2026
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
January 11, 2026
Decks in 2026
- Corporate Update (September 2026)
Corporate update · 54 slides · Sep 30, 2026
- Technical Presentation (September 2026)
Technical · 15 slides · Sep 30, 2026
- Technical Presentation (September 2026)
Technical · 16 slides · Sep 15, 2026